Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Boccara

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Critical Reviews in Oncology/Hematology|February 19, 2011
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologistsStephane Ederhy, Hassan Izzedine, Christophe Massard, et al.
Archives of Cardiovascular Diseases|April 25, 2018
Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?Yann Ancedy, Emmanuelle Berthelot, Sylvie Lang, et al.
Journal of General Internal Medicine|November 13, 2019
Treatment Bias in Management of HIV Patients Admitted for Acute Myocardial Infarction: Does It Still Exist?Gbolahan O Ogunbayo, Le Dung Ha, Qamar Ahmad, et al.
Archives of Cardiovascular Diseases|November 14, 2020
Left ventricular ejection fraction: An additional risk marker in COVID-19Laurie Soulat-Dufour, Sylvie Lang, Stephane Ederhy, et al.
AIDS (London, England)|November 14, 2008
Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapiesGilles J Thöni, Iris Schuster, Guillaume Walther, et al.
American Heart Journal|December 17, 2016
Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudyFranck Boccara, Joe Miantezila Basilua, Murielle Mary-Krause, et al.
Archives of Cardiovascular Diseases|September 24, 2008
Is the aortic root dilated in obstructive sleep apnoea syndrome?Catherine Meuleman, Franck Boccara, Xuan-Lan Nguyen, et al.
AIDS (London, England)|October 20, 2009
Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trialElisabeth Aslangul, Lambert Assoumou, Randa Bittar, et al.
Archives of Cardiovascular Diseases|May 18, 2024
Management of lipid variables in primary cardiovascular prevention: A position paper from the Heart, Vessels and Metabolism Group of the French Society of CardiologyFrançois Diévart, Eric Bruckert, Victor Aboyans, et al.
Plos One|November 22, 2014
Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infectionAnders Boyd, Jean-Luc Meynard, Laurence Morand-Joubert, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Critical Reviews in Oncology/Hematology|February 19, 2011
Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologistsStephane Ederhy, Hassan Izzedine, Christophe Massard, et al.
Archives of Cardiovascular Diseases|April 25, 2018
Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation?Yann Ancedy, Emmanuelle Berthelot, Sylvie Lang, et al.
Journal of General Internal Medicine|November 13, 2019
Treatment Bias in Management of HIV Patients Admitted for Acute Myocardial Infarction: Does It Still Exist?Gbolahan O Ogunbayo, Le Dung Ha, Qamar Ahmad, et al.
Archives of Cardiovascular Diseases|November 14, 2020
Left ventricular ejection fraction: An additional risk marker in COVID-19Laurie Soulat-Dufour, Sylvie Lang, Stephane Ederhy, et al.
AIDS (London, England)|November 14, 2008
Silent cardiac dysfunction and exercise intolerance in HIV+ men receiving combined antiretroviral therapiesGilles J Thöni, Iris Schuster, Guillaume Walther, et al.
American Heart Journal|December 17, 2016
Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudyFranck Boccara, Joe Miantezila Basilua, Murielle Mary-Krause, et al.
Archives of Cardiovascular Diseases|September 24, 2008
Is the aortic root dilated in obstructive sleep apnoea syndrome?Catherine Meuleman, Franck Boccara, Xuan-Lan Nguyen, et al.
AIDS (London, England)|October 20, 2009
Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trialElisabeth Aslangul, Lambert Assoumou, Randa Bittar, et al.
Archives of Cardiovascular Diseases|May 18, 2024
Management of lipid variables in primary cardiovascular prevention: A position paper from the Heart, Vessels and Metabolism Group of the French Society of CardiologyFrançois Diévart, Eric Bruckert, Victor Aboyans, et al.
Plos One|November 22, 2014
Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infectionAnders Boyd, Jean-Luc Meynard, Laurence Morand-Joubert, et al.
Pageof 14